Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03328143 · ClinicalTrials.gov registry record · Phase 1
Feasibility of Aromatherapy in an Awake Craniotomy Environment
A Phase 1 study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
NCT03328143 is a Phase 1 study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 40 participants.
The verdict
NCT03328143, a Phase 1 study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
Study Summary
Awake craniotomy for tumor surgery allows for mapping of speech, motor and sensory function during tumor resection. Awake craniotomy is increasingly utilized as it has several advantages over a traditional general anesthetic technique. Though many patients tolerate awake cranial surgery well, recent studies found that roughly 30% of patients experience moderate to severe pain and anxiety, while 50% report moderate fear and 11% report severe fear. Therefore, alternative methods to mitigate pain, anxiety, and fear are needed. In this study, the investigators will employ lavender aromatherapy to reduce anxiety and improve the satisfaction with pain control.
Interventions
- DRUG Lavender (Lavandula angustifolia)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2018-04-03 |
| Est. Completion | 2019-06-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03328143
The ClinicalTrials.gov registry entry for NCT03328143 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lavender (Lavandula angustifolia) is the first listed.
NCT03328143 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03328143 about?
NCT03328143 is a clinical study titled "Feasibility of Aromatherapy in an Awake Craniotomy Environment". Awake craniotomy for tumor surgery allows for mapping of speech, motor and sensory function during tumor resection. Awake craniotomy is increasingly utilized as it has several advantages over a traditional general anesthetic technique. Though many patients tolerate awake cranial surgery well, recent...
What is the current status of trial NCT03328143?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2018-04-03. Estimated completion is 2019-06-12.
What interventions are being tested in trial NCT03328143?
The interventions under investigation include: Lavender (Lavandula angustifolia) (DRUG).
Who is sponsoring clinical trial NCT03328143?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.